C35 - Pathogenetic mutations in BRCA related triple negative breast cancer

Autor: Bini, F., Ballatore, Z., Bianchi, F., Maccaroni, E., Belvederesi, L., Brugiati, C., Pagliaretta, S., Murrone, A., Savini, A., Pistelli, M., Bracci, R., Berardi, R.

Publikováno v: In Annals of Oncology October 2017 28 Supplement 6:vi34-vi35

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Autor: Belderbos, Robert A., Baas, Paul, Berardi, Rossana, Cornelissen, Robin, Fennell, Dean A., van Meerbeeck, Jan, Scherpereel, Arnaud, Vroman, Heleen, Aerts, Joachim G. J., V, Bezemer, K., Rafaelian, A., Poncin, M., Goktas, I, Braakman, E., van Hove, L., Klok, J., Geel, A., de Vries, M., Janssens, Annelies, Zhang, Xiang, Raskin, Jo, Kohl, Siska, Hufkens, Annemie, Claes, Rita, Willemin, M. C., Wasielewski, E., Grammont, M., Batista, S., Pinturaud, M., Ballatore, Z., Lucarelli, A., Burattini, M., Tonnini, C., Bianchi, F., Pagliaretta, S., Hudka, M., Lord, K., Darlison, L., Varadhan, B., Hunter, A.

Publikováno v: Translational lung cancer research
Translational Lung Cancer Research, 8(3), 280-285. Society for Translational Medicine (STM)
Translational Lung Cancer Research

BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive, treatment resistant neoplasm. The current treatment, consisting of antifolate and platinum-based chemotherapy, improves the median overall survival with only 3 months. Adjuvant bevaci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f521f512f42d764c2b193c5aaf43990
https://hdl.handle.net/10067/1613550151162165141

H8 - Prognostic impact of CA15-3 pre-treatment levels in ovarian cancer patients

Autor: Maccaroni, E., Giampieri, R., Del Prete, M., Principi, G., Bracci, R., Calcinari, A., Della Mora, A., Bianchi, F., Belvederesi, L., Brugiati, C., Pagliaretta, S., Pistelli, M., Savini, A., Pagliacci, A., Ballatore, Z., Bini, F., Baleani, M.G., Cantini, L., Murrone, A., Berardi, R.

Publikováno v: In Annals of Oncology October 2017 28 Supplement 6:vi71-vi72

M03 - Phosphoinositide-3-kinase single-nucleotide polymorphisms frequencies between malignant melanoma patients and healthy volunteers shared by sex

Autor: Morgese, F., Pagliaretta, S., Rinaldi, S., Torniai, M., Savini, A., Onofri, A., Soldato, D., Fabbri, A., Berardi, R.

Publikováno v: In Annals of Oncology September 2016 27 Supplement 4:iv89-iv89

F24 - Triple-negative breast cancer and BRCA mutation: looking at the future

Autor: Ballatore, Z., Pistelli, M., Bracci, R., Bianchi, F., Maccaroni, E., Belvederesi, L., Brugiati, C., Pagliaretta, S., De Lisa, M., Della Mora, A., Cantini, L., Bastianelli, L., Pagliacci, A., Battelli, N., Berardi, R.

Publikováno v: In Annals of Oncology September 2016 27 Supplement 4:iv66-iv66